Roquefort Therapeutics plc Stock price
Equities
ROQ
GB00BMDQ2T15
Investment Management & Fund Operators
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7 GBX | -3.45% | -3.45% | -3.45% |
Sales 2021 | 637 804.06 | Sales 2022 | - | Capitalization | 8.56M 10.8M |
---|---|---|---|---|---|
Net income 2021 | - 0 | Net income 2022 | -1M -1.26M | EV / Sales 2021 | 10,439 x |
Net cash position 2021 | 900K 1.14M | Net cash position 2022 | 2.32M 2.93M | EV / Sales 2022 | - |
P/E ratio 2021 |
-3.77
x | P/E ratio 2022 |
-4.24
x | Employees | 9 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 48.51% |
1 day | -3.45% | ||
1 week | -3.45% | ||
Current month | -17.65% | ||
1 month | -20.00% | ||
3 months | -6.67% | ||
6 months | -8.20% | ||
Current year | -3.45% |
Managers | Title | Age | Since |
---|---|---|---|
Ajan Reginald
CEO | Chief Executive Officer | 52 | 22-09-15 |
Chairman | 51 | 20-08-16 | |
Armand Keating
CTO | Chief Tech/Sci/R&D Officer | - | 22-09-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jean Duvall
BRD | Director/Board Member | 63 | 22-04-04 |
Darrin Disley
BRD | Director/Board Member | 57 | 22-09-15 |
Chairman | 51 | 20-08-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 7 | -3.45% | 277,459 |
24-03-27 | 7.25 | 0.00% | 168,143 |
24-03-26 | 7.25 | 0.00% | 0 |
24-03-25 | 7.25 | 0.00% | 33,551 |
24-03-22 | 7.25 | 0.00% | 0 |
Delayed Quote London S.E., March 28, 2024 at 12:35 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-3.45% | 11.82M | |
+2.70% | 124B | |
+6.28% | 100B | |
+21.88% | 64.53B | |
+6.62% | 62.83B | |
+15.43% | 43.68B | |
+10.70% | 42.86B | |
+16.03% | 34.12B | |
+13.21% | 27.03B | |
-0.18% | 23.21B |